AJP - Heart and Circulatory Physiology, Vol 265, Issue 5 1744-H1749, Copyright © 1993 by American Physiological Society

ARTICLES

Involvement of the "tethered ligand" receptor in thrombin-induced endothelium-mediated relaxations

B. Tesfamariam, G. T. Allen, D. Normandin and M. J. Antonaccio
Department of Pharmacology, Bristol-Myers Squibb Research Institute, Princeton, New Jersey 08543.

The mechanisms by which the serine protease, alpha-thrombin, mediates relaxations were examined in isolated dog and pig coronary arteries and dog saphenous veins. In rings of coronary arteries and saphenous veins contracted submaximally with prostaglandin F2 alpha or U46619, alpha-thrombin (0.1-10 nM) caused relaxations that were abolished by treatment with N omega-nitro-L-arginine (L-NNA) or removal of the endothelium, indicating that the relaxations were mediated by endothelium-derived nitric oxide. These relaxations were blocked by the thrombin active site inhibitor, MD-805, indicating the requirement of thrombin's catalytic site to induce the relaxations. The thrombin exosite inhibitor, BMS-180742, decreased the sensitivity to alpha-thrombin without altering maximal relaxations. Indomethacin, a cyclooxygenase inhibitor, had no inhibitory effect on the relaxations caused by alpha-thrombin, indicating that the relaxations were not mediated by cyclooxygenase products. Similar to alpha-thrombin, the thrombin receptor activating peptide (human sequence: SFLLRNP, 1-100 microM) caused relaxations in pig coronary artery and dog saphenous vein but not in dog coronary artery. These relaxations were blocked by L-NNA but not by indomethacin. The results indicate that alpha-thrombin induces endothelium-dependent relaxations by a novel signaling mechanism that involves proteolytic cleavage of the thrombin receptor to expose a new amino terminus that functions as a "tethered peptide ligand" to activate thrombin receptors on the endothelial cells and release nitric oxide.

This article has been cited by other articles:

				I. J. Gudmundsdottir, I. L. Megson, J. S. Kell, C. A. Ludlam, K. A.A. Fox, D. J. Webb, and D. E. Newby Direct Vascular Effects of Protease-Activated Receptor Type 1 Agonism In Vivo in Humans Circulation, October 10, 2006; 114(15): 1625 - 1632. [Abstract] [Full Text] [PDF]

				E. A. Peterson, M. R. Sutherland, M. E. Nesheim, and E. L. G. Pryzdial Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2 J. Cell Sci., June 15, 2003; 116(12): 2399 - 2408. [Abstract] [Full Text] [PDF]

				J. J. Bosnjak, K. Terata, H. Miura, A. Sato, A. C. Nicolosi, M. McDonald, S. A. Manthei, T. Saito, O. A. Hatoum, and D. D. Gutterman Mechanism of thrombin-induced vasodilation in human coronary arterioles Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1080 - H1086. [Abstract] [Full Text] [PDF]

				C. Patterson, G. A. Stouffer, N. Madamanchi, and M. S. Runge New Tricks for Old Dogs : Nonthrombotic Effects of Thrombin in Vessel Wall Biology Circ. Res., May 25, 2001; 88(10): 987 - 997. [Abstract] [Full Text] [PDF]

				E. Arnaud, V. Nicaud, O. Poirier, F. Rendu, M. Alhenc-Gelas, J.-N. Fiessinger, J. Emmerich, and M. Aiach Protective Effect of a Thrombin Receptor (Protease-Activated Receptor 1) Gene Polymorphism Toward Venous Thromboembolism Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 585 - 592. [Abstract] [Full Text] [PDF]

				B. P. Damiano, W.-M. Cheung, R. J. Santulli, W.-P. Fung-Leung, K. Ngo, R. D. Ye, A. L. Darrow, C. K. Derian, L. de Garavilla, and P. Andrade-Gordon Cardiovascular Responses Mediated by Protease-Activated Receptor-2 (PAR-2) and Thrombin Receptor (PAR-1) are Distinguished in Mice Deficient in PAR-2 or PAR-1 J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 671 - 678. [Abstract] [Full Text]

				J. R. Hamilton, P. B. Nguyen, and T. M. Cocks Atypical Protease-Activated Receptor Mediates Endothelium-Dependent Relaxation of Human Coronary Arteries Circ. Res., June 29, 1998; 82(12): 1306 - 1311. [Abstract] [Full Text] [PDF]

				M. Molino, M. J. Woolkalis, J. Reavey-Cantwell, D. Pratico, P. Andrade-Gordon, E. S. Barnathan, and L. F. Brass Endothelial Cell Thrombin Receptors and PAR-2. TWO PROTEASE-ACTIVATED RECEPTORS LOCATED IN A SINGLE CELLULAR ENVIRONMENT J. Biol. Chem., April 25, 1997; 272(17): 11133 - 11141. [Abstract] [Full Text] [PDF]

				F. Li, D. Baykal, C. Horaist, C.-N. Yan, B. N. Carr, G. N. Rao, and M. S. Runge Cloning and Identification of Regulatory Sequences of the Human Thrombin Receptor Gene J. Biol. Chem., October 18, 1996; 271(42): 26320 - 26328. [Abstract] [Full Text] [PDF]